DataMetrex Signs Definitive Agreement to Acquire Yuzu Payment Processing Solution From Firstpayment Inc.

TORONTO, ONTARIO / ACCESS Newswire / December 10, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce further to its news releases dated September 15, 2025, September 22, 2025, September 29, 2025 November 11, 2025 and November 14, 2025, it has signed a definitive asset purchase agreement, dated December 9, 2025 (the "Definitive Agreement") to acquire via a wholly owned subsidiary, Paymetrex Payment Solutions Inc, ("Paymetrex") the Yuzu payment processing solution from Firstpayment Inc. ("Firstpayment"), a Canadian-based fintech company, including the related patents and intellectual property (the "Yuzu Payment Solution") in an arm's length transaction (the "Transaction").

Transaction Terms

Under the terms of the Definitive Agreement, Datametrex will acquire the Yuzu Payment Solution from Firstpayment for the purchase price of $5.5 million, which is satisfied through the issuance of 55,000,000 common shares in the capital of Datametrex (the "Consideration Shares"), at a deemed issue price of $0.10 per share.

Upon completion of the Transaction, it is anticipated that Michael Kron, the current CEO of Firstpayment, will join the Board of Directors of the Company and will be COO of Paymetrex.

Upon closing of the Transaction, the proceeds of the Company's previously announced private placement of subscription receipts will be released from escrow and will be used to integrate the Yuzu Payment Solution into Datametrex's technology division and to pursue merchant opportunities to generate revenue.

Completion of the Transaction is expected on or about December 17, 2025, subject to the satisfaction of all necessary customary closing conditions, including approval from TSXV and the board of directors of the Company.

About Firstpayment

Firstpayment is a Canadian-based fintech company that provides payment processing solutions including cryptocurrencies. Its technology is backed by a portfolio of ten (10) patents, seven (7) USPTOs, one (1) USPTO pending, and two (2) Canadian patents, in the payments space, including innovations in mobile and cryptocurrency payments. The company's proprietary platform, "YUZU", also known as Yuzupay, enables seamless cryptocurrency payments between merchants and customers.

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our Company website (www.datametrex.com).

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

Forward-Looking Statements

This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

###

SOURCE: DataMetrex AI Ltd.